| Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia M Solaymani-Dodaran, M Ghanei, M Bagheri, A Qazvini, E Vahedi, ... International immunopharmacology 95, 107522, 2021 | 79 | 2021 |
| Clinical characteristics and outcome of hospitalized COVID-19 patients with diabetes: A single-center, retrospective study in Iran M Akbariqomi, MS Hosseini, J Rashidiani, H Sedighian, H Biganeh, ... diabetes research and clinical practice 169, 108467, 2020 | 68 | 2020 |
| Nanoformulations of Plant-Derived Compounds as Emerging Therapeutic Approach for Colorectal Cancer H Biganeh, SM Dizaji, YD Taghipour, G Murtaza, R Rahimi Current Drug Delivery 20 (8), 1067-1094, 2023 | 4 | 2023 |
| Resveratrol as a probable multiheaded treatment approach for COVID-19 R Ahmadian, H Biganeh, Y Panahi, PC Guest, T Jamialahmadi, ... Natural Products and Human Diseases: Pharmacology, Molecular Targets, and …, 2021 | 4 | 2021 |
| Bombyx mori cocoon as a promising pharmacological agent: A review of ethnopharmacology, chemistry, and biological activities H Biganeh, M Kabiri, Y Zeynalpourfattahi, RMC Brancalhão, M Karimi, ... Heliyon, 2022 | 3 | 2022 |
| Exploiting new strategies in combating head and neck carcinoma: A comprehensive review on phytochemical approaches passing through PI3K/Akt/mTOR signaling pathway A Iranpanah, MB Majnooni, H Biganeh, R Amirian, M Rastegari‐Pouyani, ... Phytotherapy Research, 2024 | | 2024 |
| Nanotechnology in the Formulation and Delivery of Natural Products for Cancer L Dayani, H Biganeh, R Rahimi Handbook of Oncobiology: From Basic to Clinical Sciences, 2023 | | 2023 |
Roja RahimiProfessor, School of Persian Medicine, Tehran University of Medical Sciences (TUMS)
Roja RahimiProfessor, School of Persian Medicine, Tehran University of Medical Sciences (TUMS)